Skip Navigation



Nucleic Acids Research Advance Access published online on October 9, 2009

Nucleic Acids Research, doi:10.1093/nar/gkp830
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (4320K) Freely available
Right arrow Screen PDF (545K) Freely available
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Ansari, H. R.
Right arrow Articles by Raghava, G. P. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ansari, H. R.
Right arrow Articles by Raghava, G. P. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author(s) 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Database Issue

AntigenDB: an immunoinformatics database of pathogen antigens

Hifzur Rahman Ansari1, Darren R. Flower2 and G. P. S. Raghava1,*

1Bioinformatics Centre, Institute of Microbial Technology, Sector 39A, Chandigarh, India and 2The Jenner Institute, University of Oxford, High Street, Compton, Berkshire, RG20 7NN, UK

*To whom correspondence should be addressed. Tel: +91 172 2690557; Fax: +91 172 2690585; Email: raghava{at}imtech.res.in

Received July 28, 2009. Revised September 16, 2009. Accepted September 19, 2009.

The continuing threat of infectious disease and future pandemics, coupled to the continuous increase of drug-resistant pathogens, makes the discovery of new and better vaccines imperative. For effective vaccine development, antigen discovery and validation is a prerequisite. The compilation of information concerning pathogens, virulence factors and antigenic epitopes has resulted in many useful databases. However, most such immunological databases focus almost exclusively on antigens where epitopes are known and ignore those for which epitope information was unavailable. We have compiled more than 500 antigens into the AntigenDB database, making use of the literature and other immunological resources. These antigens come from 44 important pathogenic species. In AntigenDB, a database entry contains information regarding the sequence, structure, origin, etc. of an antigen with additional information such as B and T-cell epitopes, MHC binding, function, gene-expression and post translational modifications, where available. AntigenDB also provides links to major internal and external databases. We shall update AntigenDB on a rolling basis, regularly adding antigens from other organisms and extra data analysis tools. AntigenDB is available freely at http://www.imtech.res.in/raghava/antigendb and its mirror site http://www.bic.uams.edu/raghava/antigendb.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.